lebrikizumab
Eli Lilly Faces Third FDA Rejection in 2023, Eczema Drug Lebrikizumab Denied Approval
Anika Sharma
Eli Lilly, which had set ambitious plans to introduce four new drugs in 2023, has faced another setback on the ...
Almirall uses famous paintings to raise awareness of atopic dermatitis
Anika Sharma
Almirall, a Barcelona-based pharmaceutical company collaborated with Eli Lilly on the development of the atopic dermatitis drug candidate lebrikizumab, has ...
